Click here to view publications by Dr. Anne Davidson, MBBS, in PubMed.

Liu Z, Bethunaickan R, Huang W, Lodhi U, Solano I, Madaio MP, Davidson A. Interferon alpha accelerates murine SLE in a T cell dependent manner. Arthritis Rheum. 2010 Oct 15. [Epub ahead of print]
View Supplementary Data 

Ramanujam M, Bethunaickan R, Huang W, Tao H, Madaio MP, Davidson A. (2010) Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation. Arthritis Rheum. 2010 May;62(5):1457-68.

Ramanujam M, Kahn P, Huang W, Tao H, Tepas M, Alpoge E, Factor SM, Madaio MP, Davidson A. (2009) Interferon alpha treatment of NZN/BXSB F1 females mimics some but not all features associated with the Yaa mutation. Arthritis and Rheum. 2009 Apr;60(4):1096-101.

Kahn P, Ramanujam M, Bethunaickan R, Huang W, Tao H, Madaio MP, Factor SM, Davidson A. (2008) Prevention of murine anti-phospholipid syndrome by BAFF blockade. Arthritis and Rheum. 58: 2824-34. PMC2596604

Ramanujam M, A Davidson. (2008) BAFF blockade for SLE – will the promise be fulfilled? Immunological Reviews. 223: 156-74.

Ramanujam M, A Davidson. (2008) Targeting of the immune system in systemic lupus Erythematosus. Exp Rev Mol Med. Jan 21;10: e2.

Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M, Tao H, Madaio MM, Bottinger EP, Davidson A. (2008) Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol. 180: 1938-1947. PMC2587994.

Martin DA, Zhang K, Kenkel J, Hughes G, Clark E, Davidson A, Elkon KB. (2007) Autoimmunity from adoptively transferred dendritic cells is initiated by both αβ and γδ T-cells but does not require MyD88 signaling. J Immunol. 179: 5819-28.

Poutahidis T, Haigis KM, Rao VP, Nambiar PR, Taylor CL, Ge Z, Watanabe K, Davidson A, Horwitz BH, Fox JG, Erdman SE. (2007) Cytokine mediated rapid reversal of epithelial invasion in a mouse model of microbially-induced colon carcinoma. Carcinogenesis. 28(12): 2614-23.

Tomczak MF, Erdman SE, Davidson A, Wang YY, Nambiar PR, Rogers AB, Rickman B, Luchetti D, Fox JG, Horwitz BH. (2006) Inhibition of H. hepaticus-induced colitis by IL-10 requires the presence of the p50/p105 subunit of NFkB. J Immunol. 177: 7332-7339.

Davidson A, Aranow C. (2006) SLE nephritis. New mechanisms and therapies. Curr Op Rheumatology. Sep;18(5):468-75.

Ramanujam M, Wang X, Huang W, Liu Z, Schiffer L, Tao H, Frank D, Rice J, Diamond B, Yu K, Porcelli S, Davidson A. (2006) Similarities and differences between selective and non-selective BAFF blockade in murine SLE: J Clin Invest. 116:724-34.

Forestier C, Molano A, Im JS, Dutronc Y, Diamond B, Davidson A, Illarionov PA, Besra GS, Porcelli SA. (2005) Expansion and Hyperactivity of CD1d-Restricted NKT Cells during the Progression of Systemic Lupus Erythematosus in (New Zealand Black x New Zealand White) F1 Mice. J Immunol. 175(2):763-70.
[back to the top]

Davidson A, Diamond B, Wofsy D, Daikh D. (2005) Block and tackle: CTLA4Ig takes on lupus. Lupus. 14: 197-203.

Zhao Z, Weinstein E, Tuzova M, Davidson A, Mundel P, Marambio P, Putterman C. (2005) Human lupus anti-DNA antibodies cross-react with a-actinin and induce renal disease. Arthritis Rheum. 52: 522-30.

Ye Q, Wang L, Wells AD, Tao R, Han R, Davidson A, Scott ML, Hancock WW. (2004) BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses. Eur J Immunol. 34: 2750-9.

Akkerman A, Huang W, Wang X, Ramanujam M, Schiffer L, Madaio M, Factor SM, Davidson A. (2004) CTLA4Ig Prevents Initiation But Not Evolution Of Anti-Phospholipid Syndrome In NZW/BXSB Mice. Autoimmunity. Oct-Nov;37: 445-51.

Ramanujam M, Wang X, Huang W, Schiffer L, Grimaldi C, Akkerman A, Diamond B, Madaio M, Davidson A. (2004) The mechanism of action of TACI-Ig in murine SLE. J Immunol. 173: 3524-34.

Ramanujam M, Davidson A. (2004) The current status of targeting BAFF/BLyS for autoimmune diseases. Arthritis Research and Therapy. 6:197-202.

Reiser J, Loos M, von Gersdorff G, Watanabe H, Schwarz K, Faul C, Weins A, DiLorenzo TP, Kretzler M, Simons M, Wang, Schwartz JC, Nathenson S, Davidson A, Kreidberg JA, Mundel P. (2004) Promotion of cell matrix adhesion and orchestration of cell-cell contacts define novel roles of B7-1 in podocytes and proteinuric kidney diseases. J Clin Invest. 113: 1390-7.

Schiffer L, Sinha J, Wang X, Huang W, von Gersdorff G, Schiffer M, Madaio MP, Davidson A. (2003) Short term administration of costimulatory blockade and cyclophosphamide induces remission of SLE nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J Immunol. 171: 489-97.

Davidson A, Wang X, Mihara M, Ramanujam M, Huang W, Schiffer LE, Akkerman A, Sinha J. (2003) Costimulatory blockade in the treatment of murine SLE. Ann NY Acad Sci. 987: 188-198.

Wang X, Huang W, Mihara M, Schiffer L, Davidson A. (2003) Effects of anti-CD154 treatment on B cells in murine SLE. Arthritis Rheum. 48: 495-506.

Huang W, Sinha J, Newman J, Reddy B, Budhai L, Furie R, Vaishnaw A, Davidson A. (2002) The effect of anti-CD40 ligand antibody on B cells in human SLE. Arthritis Rheum. 46: 1554-62.

Wang X, Huang W, Mihara M, Sinha J, Davidson A. (2002) Mechanism of action of combined short term CTLA4Ig and anti-CD40L in murine SLE. J Immunol. 168: 2046-53.

Davidson A, Diamond B. (2001) Autoimmune diseases. New Engl J Med. 345: 340-350.

Reddy B, Gupta S, Chuzhin Y, Kalergis A, Budhai L, Zhang M, Droguett G, Horwitz M, Roy-Chowdhury J, Nathenson S, Davidson A. (2001) The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation. Transplantation. 71: 801-11.

Mihara M, Tan Y, Chuzhin B, Reddy L, Budhai A, Holzer A, Davidson A. (2000) CTLA4Ig interferes with T cell-dependent B cell maturation in murine SLE. J Clin Invest. 106: 91-101.

Zhang M, Davidson A.  (1999) A rheumatoid factor specific mimotope identified by a peptide display library. Autoimmunity. 30: 131-42.

Zhang M, Majid A, Bardwell P, Vee C, Davidson A. (1998) Rheumatoid factor specificity of a VH3 encoded antibody is dependent on the heavy chain CDR3 region and is independent of protein A binding. J Immunol. 161: 2284-9.

Ilan Y, Droguett G, Roy-Chowdhury N, Li Y, Sengupta K, Thumalla NR, Davidson A, Roy-Chowdhury J, Horwitz MS. (1997) Insertion of the adenoviral E3 region into a recombinant viral vector prevents anti-viral humoral and cellular immune responses and permits longterm gene expression. Proc Natl Acad Sci. 94: 2587-92.

Ilan Y, Prakash R, Davidson A, Jona V, Droguett G, Horwitz M, Roy-Chowdhury Y, Roy-Chowdhury J. (1997) Oral tolerization to adenoviral antigens permits long term gene expression using recombinant adenoviral vectors. J Clin Invest. 98: 2640-47.

Budhai L, Oh K, Davidson A. (1996) An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with SLE. J Clin Invest. 98: 1585-93.

Teller K, Budhai L, Zhang M, Haramati N, Keiser HD, Davidson A. (1996) HLA DRB1 and DQB typing of Hispanic-American patients with rheumatoid arthritis: the "shared epitope" hypothesis may not apply. J. Rheumatol. 23: 1363-68.

Zhang M, Spey D, Ackerman S, Majid A, Davidson, A. (1996) Rheumatoid factor idiotypic and antigenic specificity is strongly influenced by the light chain VJ junction. J Immunol. 156: 3570.

Youngblood K, Fruchter L, Ding G, Lopez J, Bonagura V, Davidson A. (1994) Rheumatoid factors from the peripheral blood of patients with rheumatoid arthritis are genetically heterogeneous and somatically mutated. J Clin Invest. 93:852.

Davidson A, Lopez J, Prus D, Sun D. (1992) A monoclonal anti-idiotype specific for human polyclonal IgM rheumatoid factor. J Immunol. 148: 3873.
[back to the top]